author-photo

Markus Eckstein

University of Erlangen-Nuremberg

160

Papers

821

Citations

Citation Trend

Filter By

Papers (117) Sort By

Journal Conference Others

High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer

2021 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (0)
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Does the precision oncology medicine development pathway deliver value for health systems

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.

2021 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (0)
Tumor budding correlates with discohesive growth pattern, tumor invasiveness and is associated with worse survival of pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (3)
First-line therapy of advanced head and neck cancer with double checkpoint blockade and radioimmunotherapy - first results.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T-cell infiltration.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)